Back to Journals » Transplant Research and Risk Management » Volume 11

Regeneration of trabecular meshwork in primary open angle glaucoma by stem cell therapy: a new treatment approach

Authors Vingolo EM, Chabib A, Anselmucci F

Received 18 November 2018

Accepted for publication 12 February 2019

Published 3 April 2019 Volume 2019:11 Pages 11—16

DOI https://doi.org/10.2147/TRRM.S160229

Checked for plagiarism Yes

Review by Single-blind

Peer reviewers approved by Dr Colin Mak

Peer reviewer comments 2

Editor who approved publication: Professor Qing Yi


Enzo Maria Vingolo, Ayoub Chabib, Federico Anselmucci

Department of Sense Organs, U.O.C. Ophthalmology, Sapienza University of Rome, Latina, Italy

Abstract: Primary open angle glaucoma (POAG) is a worldwide disease with IOP being an important risk factor for the disease. Pharmacological and surgical treatments have been mainly targeted on lowering IOP by decreasing aqueous humor production or increasing aqueous humor outflow. Stem cell therapies may open new frontiers in regenerative ophthalmology branch. In POAG there is a strong association with pathologic degeneration of the trabecular meshwork (TM) and regenerative cell-therapy approaches have been focused mainly on modulation of the degeneration. Many different adult stem cell types have been discovered in different parts of the eye such as the corneal endothelium (CE) and anterior non-filtering portion of the TM called Schwalbe’s ring region. These stem cells may supply new cells for the TM and may regenerate the TM structure thus reducing IOP and restore the homeostatic function of the eye. In this paper, we report the studies’ latest findings and present our perspective on approaches that seem promising in the management of POAG.

Keywords: glaucoma, trabecular meshwork, stem cell therapy, POAG, iPSC
 

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]